Small-aperture intraocular lens
Colin Kerr
Published: Friday, December 7, 2018
AcuFocus has received approval for an Investigational Device Exemption (IDE) from the US Food and Drug Administration (FDA) to conduct a study of its IC-8 small-aperture intraocular lens (IOL).
The IC-8 IOL is a clear monofocal lens with an embedded mini-ring or pinhole in the centre. It is designed to increase a patient’s natural range of vision by extending the focus of light rays that enter the eye.
“Achieving IDE approval was the next milestone as we seek premarket approval in the US,” said Al Waterhouse, AcuFocus Chief Executive Officer.
http://www.acufocus.com
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular
Long-awaited cellular therapies for corneal endothelial disease enter the clinic.
Balancing Innovation and Safety
Ensuring access to advanced cell therapies amid regulatory overhaul.
With Eyes on Its Future, ESCRS Celebrates Its Past
Winter Meeting offers opportunities to experiment with new concepts and formats.
Best of ESCRS Winter Meeting 2024
Following the New Generation
EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.
Refocus on Multifocals
Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.
Common Myths in Presbyopia Correction
Patient education key to satisfaction with refractive IOLs.
Reversible Multifocality
Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.
Managing a Cataract Surgery Refractive Miss
Weighing the pros and cons of options for intraocular intervention.
Unleashing OCT’s Full Potential
Performance of newest tool for corneal evaluation meets or beats older standard technologies.